Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson T Wright

Showing results (51-60 of 189) with videos related to

Pageof 19
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 17, 2021
Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment GuidelinesBrent M Egan, Jianing Yang, Michael K Rakotz, et al.
Journal of Multidisciplinary Healthcare|March 3, 2021
The Targeted Management (TEAM) Intervention for Reducing Stroke Risk in African American Men: Rationale and Study Design of a Prospective Randomized Controlled TrialCarolyn H Still, Chris Burant, Shirley Moore, et al.
Archives of Internal Medicine|July 19, 2002
Successful blood pressure control in the African American Study of Kidney Disease and HypertensionJackson T Wright, Lawrence Agodoa, Gabriel Contreras, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 26, 2021
Controlling High Blood Pressure: An Evidence-Based Blueprint for ChangeDonald E Casey, Donna M Daniel, Jay Bhatt, et al.
Journal of the American Society of Nephrology : JASN|March 10, 2012
Kidney function can improve in patients with hypertensive CKDBo Hu, Crystal Gadegbeku, Michael S Lipkowitz, et al.
American Journal of Hypertension|January 24, 2018
The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive MedicationsJoshua I Barzilay, Barry R Davis, Sara L Pressel, et al.
Journal of Diabetes and Its Complications|July 22, 2018
Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetesJoshua I Barzilay, Barry R Davis, Alokananda Ghosh, et al.
JAMA Network Open|November 18, 2020
Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member ReportCalvin L Colvin, Jordan B King, Suzanne Oparil, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2012
Longitudinal progression trajectory of GFR among patients with CKDLiang Li, Brad C Astor, Julia Lewis, et al.
Hypertension (Dallas, Tex. : 1979)|May 11, 2011
Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trialEsa M Davis, Lawrence J Appel, Xuelei Wang, et al.
Pageof 19

Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
Hypertension (Dallas, Tex. : 1979)|November 17, 2021
Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment GuidelinesBrent M Egan, Jianing Yang, Michael K Rakotz, et al.
Journal of Multidisciplinary Healthcare|March 3, 2021
The Targeted Management (TEAM) Intervention for Reducing Stroke Risk in African American Men: Rationale and Study Design of a Prospective Randomized Controlled TrialCarolyn H Still, Chris Burant, Shirley Moore, et al.
Archives of Internal Medicine|July 19, 2002
Successful blood pressure control in the African American Study of Kidney Disease and HypertensionJackson T Wright, Lawrence Agodoa, Gabriel Contreras, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 26, 2021
Controlling High Blood Pressure: An Evidence-Based Blueprint for ChangeDonald E Casey, Donna M Daniel, Jay Bhatt, et al.
Journal of the American Society of Nephrology : JASN|March 10, 2012
Kidney function can improve in patients with hypertensive CKDBo Hu, Crystal Gadegbeku, Michael S Lipkowitz, et al.
American Journal of Hypertension|January 24, 2018
The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive MedicationsJoshua I Barzilay, Barry R Davis, Sara L Pressel, et al.
Journal of Diabetes and Its Complications|July 22, 2018
Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetesJoshua I Barzilay, Barry R Davis, Alokananda Ghosh, et al.
JAMA Network Open|November 18, 2020
Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member ReportCalvin L Colvin, Jordan B King, Suzanne Oparil, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2012
Longitudinal progression trajectory of GFR among patients with CKDLiang Li, Brad C Astor, Julia Lewis, et al.
Hypertension (Dallas, Tex. : 1979)|May 11, 2011
Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trialEsa M Davis, Lawrence J Appel, Xuelei Wang, et al.
Pageof 19